
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tuning the Organ Tropism of Polymersome for Spleen‐Selective Nanovaccine Delivery to Boost Cancer Immunotherapy
Wenxing Gu, Jingnan An, Yaxi Li, et al.
Advanced Materials (2023) Vol. 35, Iss. 41
Closed Access | Times Cited: 21
Wenxing Gu, Jingnan An, Yaxi Li, et al.
Advanced Materials (2023) Vol. 35, Iss. 41
Closed Access | Times Cited: 21
Showing 21 citing articles:
Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle
Le Tu, Chonglu Li, Qihang Ding, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 13, pp. 8991-9003
Closed Access | Times Cited: 47
Le Tu, Chonglu Li, Qihang Ding, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 13, pp. 8991-9003
Closed Access | Times Cited: 47
Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 2
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 2
Targeting materials and strategies for RNA delivery
Lixin Lin, Kexin Su, Qiang Cheng, et al.
Theranostics (2023) Vol. 13, Iss. 13, pp. 4667-4693
Open Access | Times Cited: 28
Lixin Lin, Kexin Su, Qiang Cheng, et al.
Theranostics (2023) Vol. 13, Iss. 13, pp. 4667-4693
Open Access | Times Cited: 28
Engineering customized nanovaccines for enhanced cancer immunotherapy
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 15
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 15
Lymphoid organ-targeted nanomaterials for immunomodulation of cancer, inflammation, and beyond
Jessica C. Hsu, Peng Liu, Yangmeihui Song, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 15, pp. 7657-7680
Closed Access | Times Cited: 12
Jessica C. Hsu, Peng Liu, Yangmeihui Song, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 15, pp. 7657-7680
Closed Access | Times Cited: 12
Polymersomes for Therapeutic Protein and Peptide Delivery: Towards Better Loading Properties
Chengxu Hua, Liyan Qiu
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2317-2340
Open Access | Times Cited: 9
Chengxu Hua, Liyan Qiu
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2317-2340
Open Access | Times Cited: 9
Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma
Jinsong Li, GuanBo Zhang, Gang Li, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Jinsong Li, GuanBo Zhang, Gang Li, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
A Spleen‐Targeted Tolerogenic mRNA‐LNPs Vaccine for the Treatment of Experimental Asthma
Fazhan Wang, Jia Lou, Xiaohan Lou, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Fazhan Wang, Jia Lou, Xiaohan Lou, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Recent Advances of Emerging Spleen‐Targeting Nanovaccines for Immunotherapy
Xuanyi He, Jing Wang, Yuqing Tang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 23
Closed Access | Times Cited: 22
Xuanyi He, Jing Wang, Yuqing Tang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 23
Closed Access | Times Cited: 22
Ultrasound-nanovesicles interplay for theranostics
Jingyi Liu, Qing You, Fuming Liang, et al.
Advanced Drug Delivery Reviews (2024) Vol. 205, pp. 115176-115176
Closed Access | Times Cited: 8
Jingyi Liu, Qing You, Fuming Liang, et al.
Advanced Drug Delivery Reviews (2024) Vol. 205, pp. 115176-115176
Closed Access | Times Cited: 8
Glycocalyx‐Mimicking Nanoparticles with Differential Organ Selectivity for Drug Delivery and Therapy
Duhyeon Kim, Chang‐Hee Whang, Jungwoo Hong, et al.
Advanced Materials (2024) Vol. 36, Iss. 27
Closed Access | Times Cited: 8
Duhyeon Kim, Chang‐Hee Whang, Jungwoo Hong, et al.
Advanced Materials (2024) Vol. 36, Iss. 27
Closed Access | Times Cited: 8
Advances in non-viral mRNA delivery to the spleen
Eshan A. Narasipura, Owen S. Fenton
Biomaterials Science (2024) Vol. 12, Iss. 12, pp. 3027-3044
Closed Access | Times Cited: 6
Eshan A. Narasipura, Owen S. Fenton
Biomaterials Science (2024) Vol. 12, Iss. 12, pp. 3027-3044
Closed Access | Times Cited: 6
Ultrasound-powered piezocatalytic nanomotors with dual-mode synergistic/cascade propulsion reprogram hypoxic tumor-associated macrophages for enhanced cancer immunotherapy
Ke Ma, Jun-Liang Dong, Zelong Chen, et al.
Chemical Engineering Journal (2025), pp. 162107-162107
Closed Access
Ke Ma, Jun-Liang Dong, Zelong Chen, et al.
Chemical Engineering Journal (2025), pp. 162107-162107
Closed Access
Spleen cancer: Current and new drug delivery systems
Gaurav Tiwari, Saroj Adhikari Yadav, K. Kranthi Kumar, et al.
Elsevier eBooks (2025), pp. 71-100
Closed Access
Gaurav Tiwari, Saroj Adhikari Yadav, K. Kranthi Kumar, et al.
Elsevier eBooks (2025), pp. 71-100
Closed Access
Role of vesicular nanocarriers for the treatment of tuberculosis
Brojendra Nath Saren, Sayali Dighe, Saroj Kumar Jha, et al.
Elsevier eBooks (2025), pp. 99-145
Closed Access
Brojendra Nath Saren, Sayali Dighe, Saroj Kumar Jha, et al.
Elsevier eBooks (2025), pp. 99-145
Closed Access
Apoptotic Cell-Mimicking Nanocarriers Enhance Splenic Red Pulp Delivery through Lipid Pool Modulation
Di Ning, Yifan Wang, Yangyang Liu, et al.
ACS Nano (2025)
Closed Access
Di Ning, Yifan Wang, Yangyang Liu, et al.
ACS Nano (2025)
Closed Access
Personalized nanovaccines for treating solid cancer metastases
Feng Tang, Jia Hu, Jirui Wen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Feng Tang, Jia Hu, Jirui Wen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Deoxynivalenol induces spleen damage, apoptosis, and inflammation in mice by increasing mitochondrial reactive oxygen species: Protective effects of curcumin
Ying Kuang, Zuoyao Wu, Yuqin Liu
Food and Chemical Toxicology (2024) Vol. 196, pp. 115200-115200
Closed Access | Times Cited: 3
Ying Kuang, Zuoyao Wu, Yuqin Liu
Food and Chemical Toxicology (2024) Vol. 196, pp. 115200-115200
Closed Access | Times Cited: 3
Natural long-chain saturated fatty acids doped LNPs enabling spleen selective mRNA translation and potent cancer immunotherapy
Fazhan Wang, Meng Zhang, Meiling Tian, et al.
Nano Research (2023) Vol. 17, Iss. 3, pp. 1804-1817
Closed Access | Times Cited: 6
Fazhan Wang, Meng Zhang, Meiling Tian, et al.
Nano Research (2023) Vol. 17, Iss. 3, pp. 1804-1817
Closed Access | Times Cited: 6
Lung-Targeting Perylenediimide Nanocomposites for Efficient Therapy of Idiopathic Pulmonary Fibrosis
Yuting Liu, Damin Xu, Xiaoyi Xing, et al.
Nano Letters (2024)
Closed Access | Times Cited: 1
Yuting Liu, Damin Xu, Xiaoyi Xing, et al.
Nano Letters (2024)
Closed Access | Times Cited: 1
Bioresponsive Chimaeric Polymersomes Mediate Sustained and Liver-Specific siRNA Transfection In Vivo
Ri Huang, Feifei Wang, He Fu, et al.
Biomacromolecules (2023) Vol. 24, Iss. 11, pp. 5353-5363
Closed Access | Times Cited: 1
Ri Huang, Feifei Wang, He Fu, et al.
Biomacromolecules (2023) Vol. 24, Iss. 11, pp. 5353-5363
Closed Access | Times Cited: 1